MOHIT NARANG M.D.
NPI 1881695351
Internal Medicine - Medical Oncology in Owing Mills, MD

Active since August 09, 2005PECOS EnrolledAccepts Medicare Assignment
100/100
CMS Quality Rating
23 CROSSROADS DRIVE, SUITE 340, OWING MILLS, MD 21117(410) 581-2100(410) 581-2104 Get Directions Write a Review

NPPES record last updated: October 5, 2011. Verified against the NPPES registry weekly; last sync: July 26, 2026.

About Mohit Narang M.d. NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

MOHIT NARANG M.D. (NPI 1881695351) is an individual medical oncology provider in Owing Mills, Maryland, licensed in Maryland (D67468) and active in the NPI registry since August 2005. He is enrolled in Medicare PECOS, is affiliated with Johns Hopkins Howard County Medical Center, and is a graduate of Other (1995).

NPPES Registry Identity

NPI1881695351
Entity TypeIndividualMale
Primary Taxonomy207RX0202X
Provider Legal NameMOHIT NARANGCredential: M.D.
Location Address23 CROSSROADS DRIVE, SUITE 340Owing Mills, MD 21117
Mailing AddressP.o. Box 75581Baltimore, MD 21275 · (410) 964-2212 · Fax (410) 964-1111
Fax(410) 581-2104
Sole ProprietorNo
Medical School CMSOtherGraduated 1995
Enumeration DateAugust 9, 2005
Last NPPES UpdateOctober 5, 2011
NPI 1881695351 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses 2

Primary SpecialtyInternal Medicine · Medical OncologyAllopathic & Osteopathic Physicians
Taxonomy Code207RX0202X
License Licensed in MD · D67468
Definition
An internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer.
Also ListedSpecialistTaxonomy 174400000X · License E3552 (AR)
23 CROSSROADS DRIVE, Owing Mills, MD 21117

Other Identifiers 8

Medicare PIN124297YE3LPA
Medicare UPINH92163
Medicare PIN126626YZBWMD
Medicare ID-Type Unspecified5M663
Medicaid017735100MD
Medicaid1021963770001PA
Medicaid150246001AR
Medicare UPINH92163AR

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare and accepts Medicare assignment

Mohit Narang M.d. is registered in PECOS and agrees to accept the Medicare-approved amount as full payment. Medicare patients are not billed beyond the standard deductible and coinsurance.

PECOS PAC ID1951214287
PECOS Enrollment IDI20080716000351, I20180621001504
Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

Areas of Expertise CMS Part B claims 75

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Injection, darbepoetin alfa, 1 microgram (non-esrd use) J0881
Darbepoetin alfa injection is a medication used to treat anemia (low red blood cell count) often caused by chronic kidney disease or chemotherapy. It works by stimulating your body to produce more red blood cells, helping to increase your energy and well-being.
50,100 services64 patients
Injection, pembrolizumab, 1 mg J9271
Pembrolizumab is a medication given via injection to help your body's immune system fight certain types of cancer. It's typically administered in a hospital or clinic by a healthcare professional.
25,600 services23 patients
Injection, daratumumab, 10 mg and hyaluronidase-fihj J9144
Daratumumab and hyaluronidase-fihj is an injection administered to treat certain types of blood cancer. The medication works by targeting and killing specific cancer cells. It's often given under the skin to reduce side effects and improve patient comfort.
18,540 services21 patients
Injection, oxaliplatin, 0.5 mg J9263
Oxaliplatin is a chemotherapy drug that is administered via injection. It works by stopping cancer cells from growing and dividing, which helps in the treatment of certain types of cancer. The dosage is 0.5 mg, and it's important to follow your doctor's instructions for this treatment.
18,100 services16 patients
Injection, denosumab, 1 mg J0897
Denosumab is a medication given via injection to strengthen your bones. It works by slowing down the cells that break down bone, improving bone density and reducing the risk of fractures. It's often used for osteoporosis treatment.
11,580 services52 patients
Injection, nivolumab, 1 mg J9299
Nivolumab is a medication given via injection, often used in cancer treatment. It works by helping your immune system fight the cancer cells. The dosage is measured in milligrams (mg), with 1 mg being a common dose.
11,260 services12 patients

Hospital Affiliations CMS Care Compare

Hospitals where this provider delivers care, identified from recent Medicare claims and place-of-service records.

Johns Hopkins Howard County Medical Center

Acute Care Hospitals · Columbia, MD
3/5 CMS rating
OwnershipVoluntary non-profit - Private
CMS Certification Number210048
Location5755 Cedar LaneColumbia, MD 21044 · Howard County
Emergency services Birthing friendly

Physician Visit Costs CMS claims · ZIP area

Typical Medicare office-visit costs in the 21117 ZIP code area, from fee-for-service claims. These are area statistics, not this provider’s prices; actual charges vary by service and coverage.

New Patient
$183.44 typical visit price
range $60.73 – $183.44
Typical copayment $45.86 (range $15.18 – $45.86)
Most-billed visit code 99205
Established Patient
$106.59 typical visit price
range $19.60 – $149.17
Typical copayment $26.64 (range $4.90 – $37.29)
Most-billed visit code 99214
Amounts reflect what Medicare beneficiaries in this ZIP area are typically charged for office visits. Patients with other coverage should check their individual plans.

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

100/100
MIPS Final ScoreMerit-based Incentive Payment System · CMS Quality Payment Program
Individually scored
Quality100
Promoting Interoperability100
Improvement Activities40

Reported Quality Measures

Advance Care Plan
100%782 patients5/55-star benchmark: 100%
Oncology: Advance Care Planning in Metastatic Cancer Patients
74%133 patients4/55-star benchmark: 85%
Oncology: Medical and Radiation - Plan of Care for Pain
100%175 patients5/55-star benchmark: 100%
Oncology: Patient-Reported Pain Improvement
57%124 patients
Percentage of Patients Who Died from Cancer Receiving Systemic Cancer-Directed Therapy in the Last 14 Days of Life (lower score better)
Lower rates are better for this measure.
0%26 patients
Preventive Care and Screening: Screening for Depression and Follow-Up Plan
92%1,379 patients4/55-star benchmark: 97%
Provide Patients Electronic Access to Their Health Information
94%744 patients4/55-star benchmark: 100%
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Referred Medical Equipment & Supplies CMS DME claims 4

Durable medical equipment, devices and supplies this provider ordered from DME suppliers for patients, from Medicare fee-for-service claims.

Capecitabine, oral, 500 mg J8521
Treatment-Treatment - Miscellaneous · category RX029N
3 suppliers40 claims3,136 services$0.72 avg. paid by Medicare
Temozolomide, oral, 5 mg J8700
Treatment-Treatment - Miscellaneous · category RX000N
1 supplier11 claims3,790 services$0.24 avg. paid by Medicare
Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period Q0511
Treatment-Chemotherapy · category RH012N
3 suppliers40 claims40 services$17.51 avg. paid by Medicare
Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period Q0512
Treatment-Chemotherapy · category RH012N
3 suppliers18 claims25 services$12.14 avg. paid by Medicare
Dollar amounts are the average Medicare paid the supplier per service. They are not the cost to the patient.

Other Providers at the Same Location NPPES 4

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Ophthalmology
23 CROSSROADS DRIVE, SUITE 100
OWINGS MILLS, MD 21117
Clinical Medical Laboratory
23 CROSSROADS DRIVE, SUITE 130
OWINGS MILLS, MD 21117
Clinic/Center (Ambulatory Surgical)
23 CROSSROADS DRIVE, STE 100
OWINGS MILLS, MD 21117
Surgery
23 CROSSROADS DRIVE, SUITE 100
OWINGS MILLS, MD 21117

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Mohit Narang's NPI number?

The NPI number for Mohit Narang is 1881695351. It was assigned to this individual provider in the NPPES registry on August 9, 2005.

Where is Mohit Narang located?

Mohit Narang practices at 23 Crossroads Drive Suite 340, Owing Mills, MD 21117. The listed phone number is (410) 581-2100.

What is Mohit Narang's specialty?

The primary specialty registered for this NPI is Internal Medicine, specializing in Medical Oncology, with taxonomy code 207RX0202X.

Is Mohit Narang enrolled in Medicare?

Yes. Mohit Narang is registered in the Medicare PECOS system and accepts Medicare assignment, which means accepting the Medicare-approved amount as payment in full for covered services.

Is Mohit Narang affiliated with any hospitals?

According to CMS data, Mohit Narang is affiliated with Johns Hopkins Howard County Medical Center.

When was this NPI record last updated?

The NPPES record for Mohit Narang was last updated on October 5, 2011. NPI Profile syncs with the weekly NPPES data releases published by CMS.